DOXORUBICIN AND 5-FLUOROURACIL PLASMA-CONCENTRATIONS AND DETECTABILITY IN PAROTID-SALIVA

被引：27

作者：

CELIO, LA ^{[1
]}

DIGREGORIO, GJ ^{[1
]}

RUCH, E ^{[1
]}

PACE, J ^{[1
]}

PIRAINO, AJ ^{[1
]}

机构：

[1] HAHNEMANN MED UNIV, DEPT PHARMACOL, PHILADELPHIA, PA 19102 USA

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 24卷 / 02期

关键词：

D O I：

10.1007/BF00613829

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：261 / 266

页数：6

共 30 条

[1]

ABMERSJO VE, 1980, ACTA PHARM TOXICOL C, V46, P329

[2]

ANAND C, 1975, J ANAT, V119, P1

[3] 5 YEARS CLINICAL EXPERIENCE WITH 5-FLUOROURACIL [J].

ANSFIELD, FJ ;

CURRERI, AR ;

SCHROEDER, JM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 181 (04) :295-+

[4]

BACHUR NR, 1977, CLIN PHARMACOL THER, V21, P70

[5] RAPID-DETERMINATION OF DOXORUBICIN AND ITS FLUORESCENT METABOLITES BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].

BAURAIN, R ;

DEPREZDECAMPENEERE, D ;

TROUET, A .

ANALYTICAL BIOCHEMISTRY, 1979, 94 (01) :112-116

[6]

BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO

[7]

2-M

[8] ADRIAMYCIN - REVIEW [J].

CARTER, SK .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (06) :1265-1274

[9]

CHRISTOPHIDIS N, 1979, CLIN CHEM, V25, P83

[10]

CREAVEN PJ, 1979, B CANCER, V66, P85

← 1 2 3 →